Best Life Sciences Platforms and Tools Companies in Florida, United States
The 78 best Life Sciences Platforms and Tools companies in Florida, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Detraxi.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Florida
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Detraxi Provider of platform to manage urgent global health issues | $100M | 59 mo ago | 1 | 2001 | — | — | — | — |
| 2 | Blink Bio Develops technologies for targeted delivery of therapeutics | $59M | 83 mo ago | 8 | 2009 | — | — | — | — |
| 3 | X-VAX Technology Developer of virus-based vaccines for treating herpes | $56M | 83 mo ago | 12 | 2017 | — | — | — | — |
| 4 | Hesperos Developer of organ-on-a-chip solutions for preclinical testing | $29M | 13 mo ago | 15 | 2015 | James Hickman Co-Founder | — | 11 patents Patents concentrated in transport & manufacturing processes | — |
| 5 | CORD:USE Cord Blood Provider of umbilical cord blood stem cell storage services | $27M | 111 mo ago | — | 2004 | Edward Guindi President & CEO | — | — | — |
| 6 | Teewinot Life Sciences Online game platform offering latest games with easy wins | $20M | 109 mo ago | 2 | 2015 | — | — | — | — |
| 7 | Emmune Biotechnology startup developing novel HIV treatment and prevention solutions | $18M | 13 mo ago | 7 | 2013 | Michael Alpert Co-Founder | — | 25 patents Engineered protein therapeutics and scaffolded vaccine antigens for immune modulation | — |
| 8 | PositiveID Corporation Developer of biological detection and diagnostics solutions | $11M | 161 mo ago | 30 | 2001 | — | — | 4 patents Portable wireless chemical sensors for real-time acetone detection in gas streams | — |
| 9 | Firebird Biomolecular Sciences Provider of modified DNA as reagents for research, synthetic biology, and diagnostics | $7M | 17 mo ago | 9 | 2005 | Steven Benner Founder | — | — | — |
| 10 | Dyadic Developer of microbial platforms for various applications | $5M | 133 mo ago | 6 | 1979 | — | WordPressMySQLPHP+19 | 30 patents Engineering filamentous fungi and enzymes for lignocellulose conversion and bioprocessing | 1 launch · 1 partnership · 1 expansion |
| 11 | InteGen Provider of cytogenetics, DNA FISH probes for research application | $5M | 92 mo ago | 4 | 2011 | Ramesh Babu Founder & CEO | — | — | — |
| 12 | Cryo-Cell Provider of a cord blood bank to store stem cells | $3M | 318 mo ago | 82 82 → 161 (+96%) | 1989 | David Portnoy Chairman and Co-CEO | Kentico CMSSalesforceMicrosoft ASP.NET+13 | 55 patents Regenerative therapies using menstrual blood‑derived multipotent stem cells for stroke and wound healing | — |
| 13 | Genetic Networks Accelerating drug development through modular biology and whole-genome analysis | $2M | 83 mo ago | 11 | 2015 | Gennaro D'urso Founder and Chairman | — | — | — |
| 14 | Deluge Biotechnologies Developer of peptide-inspired constrained oligomers for the synthesis and screening of DNA-encoded | $2M | 15 mo ago | 15 | 2017 | Thomas Kodadek Co-Founder | — | — | — |
| 15 | Source Molecular Provider of technology for microbial source tracking | $2M | 107 mo ago | 13 | 2002 | — | — | — | — |
| 16 | Greyson Intl Speciality pharma company that develops and markets prescription and OTC skin care products | $2M | 166 mo ago | — | 1997 | Mukesh Prasad CEO & President | — | — | — |
| 17 | NanoEngineering Developer of nano-particle based virus screening technologies | $1M | 82 mo ago | 9 | 2003 | Charles Powell CEO | — | — | — |
| 18 | Quthero Developer of a patented gel platform technology for wound management | $1M | 27 mo ago | 3 | 2017 | Milica Radisic Co-Founder | — | 7 patents Peptide‑hydrogel formulations for skin therapy and immune‑modulating wound care | — |
| 19 | SynDaver Synthetic humans and animals for medical simulation, training, and device testing | $1M | 130 mo ago | 176 | 2004 | Christopher Sakezles Founder & CEO | Cart FunctionalityWooCommerceWordPress+32 | 13 patents Medical simulation models for canine anatomy and procedural training devices | — |
| 20 | TissueLabs Provider of a platform for creating organs and tissues in the lab | $800K | 27 mo ago | 13 | 2018 | — | Wix eCommerceWixSentry+22 | — | 1 partnership |
| 21 | TransGenex Developer of 3D cell culture solutions and services for biopharma | $681K | 132 mo ago | 6 | 2004 | Shyam Mohapatra Co-Founder & Chairman | — | — | — |
| 22 | Micro-gRx Developer of biological platforms for medical treatments and therapies on Earth | $382K | 20 mo ago | — | 2014 | Siobhan Malany Founder | — | — | — |
| 23 | Accentia Biopharmaceuticals Drugs and medical devices for autoimmune diseases | $375K | 168 mo ago | — | 2002 | Francis Odonnell CEO | — | 34 patents Optimizing high-dose oxazaphosphorine chemotherapy with patient selection, combo biologics, and mucositis care | — |
| 24 | Rapid Genomics Provider of DNA sequencing services for the improvement of crops and livestocks | $300K | 128 mo ago | 30 | 2011 | — | — | 20 patents Targeted high-throughput DNA sequencing and genomic region capture technologies. | — |
| 25 | Evolugate Harnessing the evolutionary process to develop useful microbial strains | $240K | 134 mo ago | — | 2005 | — | — | 2 patents Engineering microbial strains for agricultural biotech applications, such as crop protection and yield enhancement. | — |
| 26 | Aurita Bioscience Corporation Developer of three-dimensional bioscience products and tools for research and clinical settings | $180K | 25 mo ago | 5 | 2021 | — | — | — | — |
| 27 | Epigenetix Pioneering epigenetic therapies for cancer, targeting novel drug discovery and development | $167K | 117 mo ago | — | 2011 | Joseph Collard Cofounder CEO | — | 18 patents Pharmaceutical benzimidazole compounds and their controlled‑release formulations | — |
Top 12 Life Sciences Platforms and Tools companies in Florida
#1
Funding Raised · Orlando, Florida · founded 2015 · 15 employees$29.1Mraised▾
Developer of organ-on-a-chip solutions for preclinical testing. The company has a heart-liver two organ model, heart-liver- skeletal muscle-neuron organ model, neuromuscular junction organ model, and heart-liver-cancer two organ model. These are a pumpless body-on-a-chip platform that uses a serum-free cellular medium, integrated computer modeling software, and physiological monitoring solutions.
- Apr 2025Grant (prize money)$2M
- Aug 2021Grant (prize money)$2M
- Sep 2020Grant (prize money)$1.8M
- Sep 2018Grant (prize money)$1.7M
#2
Funding Raised · Jupiter, Florida · founded 2013 · 7 employees$17.5Mraised▾
Biotechnology startup developing novel HIV treatment and prevention solutions. The company is focused on addressing the HIV pandemic through innovative approaches. Their primary solution, eCD4-Ig AAV, represents a novel method for combating HIV infection. The company's mission is centered around creating effective tools for both treating existing HIV infections and preventing new ones. They are dedicated to research and development in the field of biotechnology, specifically targeting infectious diseases. The company operates as a biotechnology firm, contributing to advancements in medical science and public health. Their work has a direct social impact by addressing a global health challenge.
- May 2025Grant (prize money)$300K
- Aug 2023Grant (prize money)$2.3M
- Jan 2023Grant (prize money)$300K
- Mar 2022Grant (prize money)$3.2M
#3
Funding Raised · Gainesville, Florida · founded 2005 · 9 employees$7.3Mraised▾
Provider of modified DNA as reagents for research, synthetic biology, and diagnostics. The company's products include reversible terminators (oxime blocked and disulfide-linked tags), artificially expanded genetic information systems, modified nucleosides, phosphoramides, triphosphates, and polymerases, and Self-Avoiding Molecular Recognition Systems (a species of DNA that can bind via simple rules to natural DNA but cannot bind to other members of the same SAMRS species), Universal (TM) nucleotides, SNAP2 (TM) Oligonucleotides for high specificity and high discrimination binding of primers, and selenium-containing phosphoramidites that help speed up crystallization of oligonucleotides.
- Jan 2025Grant (prize money)$243.2K
- Feb 2022Grant (prize money)$243.2K
- Apr 2021Grant (prize money)$258.9K
- Sep 2017Grant (prize money)$136.4K
#4
Funding Raised · Jupiter, Florida · founded 2017 · 15 employees$1.7Mraised▾
Developer of peptide-inspired constrained oligomers for the synthesis and screening of DNA-encoded. The company uses macrocyclic PICCO molecules that involved in the binding process of protein-protein interaction regions and allosteric sites. It also uses a novel FACS-based technology that maintains each molecule in the library & promotes isolation of selective ligands.
- Mar 2025Grant (prize money)$1.5M
- Mar 2025Grant (prize money)$265.5K
#5
Funding Raised · Orlando, Florida · founded 2014$382.1Kraised▾
Developer of biological platforms for medical treatments and therapies on Earth. The company integrates biology platforms with payload hardware to solve issues related to spaceflight. It focuses on understanding human biology in extraterrestrial environments. The company develops new therapies to help fight diseases and biological ailments.
- Oct 2024Grant (prize money)$382.1K
#6
Series C · Jupiter, Florida · founded 2001 · 1 employees$100Mraised▾
Detraxi provider of the platform to manage urgent global health issues. It offers its solution for blood donation and organ donation management. It also offers its patent-pending technology Lifor which is used in the preservation of cells, tissues, and organs by refrigerated temperature, cryopreservation, and room temperature preservation by providing better nutrition to the cell.
- Jun 2021Grant (prize money)$50K
- Mar 2020Series C$100M
#7
Series D · Jupiter, Florida · founded 2009 · 8 employees$59.3Mraised▾
Blink Bio, formerly known as Coferon, develops technologies for targeted delivery of therapeutics. It uses its proprietary Tunable Linker Technology (bio-orthogonal linker chemistry) that enables delivery of multiple drug payloads to specific targets. Primary clinical focus is oncology, with four drugs in discovery stage testing.
- Jul 2019Conventional Debt$525K
- Apr 2019Series D$1.3M
- Jan 2019Series D$3.4M
- Jun 2018Series D$808.4K
#8
Seed · Miami, Florida · founded 2017 · 3 employees$1.4Mraised▾
Developer of a patented gel platform technology for wound management. It offer gel for post-surgical scarring prevention and is used for full epithelial restoration.
- Mar 2024Seed$1.4M
#9
Deadpooled · Jupiter, Florida · founded 2017 · 12 employees$56.5Mraised▾
Developer of virus-based vaccines for treating herpes. The vaccines also target other pathogens such as influenza, tuberculosis, and HIV. The company is developing the vaccine gD-2, which is a virus-based vaccine. Their platform enables the inserting of genes from other pathogens like the influenza virus.
- Jul 2019Series A$56.5M
- Sep 2016Seed$100K
#10
Seed · Miami, Florida · founded 2018 · 13 employees$800Kraised▾
Provider of a platform for creating organs and tissues in the lab. The platform combines sophisticated 3D bioprinting systems with tissue-specific biomaterials to enable researchers to create complex, functional 3D tissue models and organ structures. The company's products include the TissueStart and TissueRay 3D bioprinters, which support precise fabrication of tissue scaffolds and organ-on-a-chip systems, as well as MatriXpec, a proprietary line of tissue-specific hydrogels and biomaterials that mimic the natural extracellular matrix of different tissue types.
- Mar 2024Seed$800K
#11
Acquired · Orlando, Florida · founded 2004$27Mraised▾
Provider of umbilical cord blood stem cell storage services. The company engages in processing and storing a newborn’s umbilical cord blood for the possible future use by that individual or their family members; and Public Cord Blood Bank, which collects processes, and stores donated cord blood to be made publically available for patients in need of a transplant.
- Mar 2017Series A$250K
- Mar 2016Series A$875K
- Jul 2015Series A$3M
- Jul 2014Series A$15.3M
#12
Series B · Tampa, Florida · founded 2015 · 2 employees$19.9Mraised▾
Online game platform offering latest games with easy wins. It provides a platform for online gaming enthusiasts seeking the newest games and opportunities for easy wins. The platform focuses on delivering a thrilling and engaging gaming experience. It offers a variety of games designed to cater to different player preferences. The site emphasizes user-friendliness and accessibility, ensuring players can easily navigate and enjoy the available games. It aims to provide a fun and rewarding experience for its users. The platform is designed for those looking for entertainment and the chance to win while playing online games. The website includes features such as login, cart, and subscription options.
- May 2017Series B$12.3M
- Mar 2016Series A$7M
- Feb 2016Seed$587.5K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Florida is moving
A read on the academic research around Bioinformatics in Florida — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 309 papers.
- University of Florida108
- Mayo Clinic in Florida80
- Florida College40
- University of South Florida32
- Florida State University22
- Gene1→11
- RNA editing1→4
- Immune system1→4
- Sequence (biology)1→3
- Disease2→17
- Gene1→10
- Transcriptome1→7
- Disease9
- Microbiome7
- Cancer5
- MEDLINE4
- Gut microbiome4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.